Literature DB >> 26840870

Status Epilepticus: Do Treatment Guidelines Make Sense?

Iris Unterberger1.   

Abstract

Status epilepticus represents an acute, potentially life-threatening emergency with considerable risks of morbidity and mortality, mainly depending on age at onset, underlying etiology, seizure severity, and medical comorbidities. Recent European and North American guidelines on management and treatment of status epilepticus strongly recommend prompt treatment to prevent further complications. At present, following a staged treatment protocol is recommended. Benzodiazepines are the treatment of choice in early status epilepticus, but there are no class I data supporting treatment recommendations on the choice of antiepileptic drugs for established and refractory status epilepticus. This article reviews advantages and potential drawbacks of the available guidelines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26840870     DOI: 10.1097/WNP.0000000000000222

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  2 in total

Review 1.  Timing is everything: Where status epilepticus treatment fails.

Authors:  Chloe E Hill; Alomi O Parikh; Colin Ellis; Jennifer S Myers; Brian Litt
Journal:  Ann Neurol       Date:  2017-07-29       Impact factor: 10.422

2.  Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting.

Authors:  Alexander B Ramos; Roberto A Cruz; Nicole R Villemarette-Pittman; Piotr W Olejniczak; Edward C Mader
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.